MNKD 10x Potential, High R/R

Rapidly Hiring. They have a proprietary drug delivery platform known as the Technosphere. They deliver drugs through the lungs instead of injection or pills.

Afrezza their FDA approved drug is finally starting to generate sales after being fda approved years ago.

They are also working on several other products for 2020.

Huge accumulation range and due to very aggressive short sellers flooding the market with over 40 million additional shares over the years.

All of these short sales will eventually be pressured to rebuy rapidly driving up price. There are also warrants that were delayed and expire in July.

With the healthcare sector and biotech improving at a rapid pace, an effective product, all the catalysts are there.

Comment: Target is still $8
Comment: $10
Comment: Update to $20


Totally agree with you. THis is a longterm hold for me. My wife is a diabetes educator. This company is going to do great things and I believe the stock will sky rocket in the next 5-10 years. Will have to come back then and see. 2500 shares avg. 2.58
+1 Reply
v interesting and On point analysis bro !!
+1 Reply
Home Stock Screener Forex Screener Crypto Screener Economic Calendar About Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out